Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping
NCT03885765 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2025-06-22
Summary
The primary objective of the CLIPPCAIR study is to construct and validate a new algorithm for predicting post-operative forced expiratory volume in 1 second (FEV1) values for lung resection candidates; this new model will be based on data derived from a thoracic CT scan with injection of contrast media.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Predictive data
The novel predictive data in this study includes 5 predefined variables derived from thoracic CT scans: (i) Expiratory to inspiratory ratio of mean lung density (MLDe/i), total; (ii) MLDe/i of the section to be excised / MLDe/i total; (iii) Percentage of emphysema according to voxel thresholding at -950 HU (PVOX-950), total; (iv) PVOX-950 for the section to be excised; (v) Iodine concentration \[I\] of the section to be excised / \[I\] total.
- PROCEDURE
-
Lung resection
Surgical resection will be characterised by type (pneumonectomy, bi-lobectomy, lobectomy, or lobectomy with anastomosis resection), whether or not lymph node dissection was performed, and whether or not the resection was atypical.
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
Sébastien Bommart, MD · University Hospitals of Montpellier, France
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-21
- Primary Completion
- 2025-04-18
- Completion
- 2025-04-18
Countries
- France
Study Locations
More Related Trials
-
Radiomics for prEdiction of lunG cAncer biologY
NCT05819905 ·Status: UNKNOWN
-
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
NCT03791034 ·Status: RECRUITING
-
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440 ·Status: TERMINATED
-
Early Detection of Lung Cancer
NCT03181256 ·Status: ACTIVE_NOT_RECRUITING
-
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
NCT04165564 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During Prehabilitation
NCT04041297 ·Status: COMPLETED
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function
NCT03357094 ·Status: UNKNOWN
-
Pilot Study of Regional Lung Ventilation
NCT03077113 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer
NCT01799395 ·Status: TERMINATED
-
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
NCT02562027 ·Status: COMPLETED ·Phase: NA
-
Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma
NCT03156868 ·Status: COMPLETED
-
High Definition Medicine for Solid Tumors Oncology
NCT06590506 ·Status: RECRUITING
-
Factors Determining the Prognosis in NSCLC Stage IV
NCT04306094 ·Status: UNKNOWN
-
Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)
NCT03334864 ·Status: RECRUITING
-
Comparison of SPECT/CT Perfusion and Volumetric CT Volume
NCT06600204 ·Status: COMPLETED
-
Computed Tomography (CT) Perfusion Imaging of Lung Cancer
NCT00905801 ·Status: TERMINATED ·Phase: NA
-
Post-Operative Prediction of PulmonarY Function
NCT06494254 ·Status: RECRUITING
-
Centralized Lung Cancer Screening Engagement in At-Risk Populations
NCT07216144 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Clinical and Molecular Staging of Lung Cancer Stages I and IIp
NCT03286036 ·Status: UNKNOWN
-
Non-Invasive Ventilation Preoperative Lung Resection Surgery
NCT01685580 ·Status: COMPLETED ·Phase: NA
-
Improving Pulmonary Function Following Radiation Therapy
NCT02843568 ·Status: COMPLETED ·Phase: NA
-
Fast Tracking in VATS Lobectomy: A Prospective, Historically Controlled, Propensity-Matched Clinical Trial
NCT02584322 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of PD-L1 in NSCLC
NCT03078959 ·Status: UNKNOWN
-
Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer
NCT06244355 ·Status: RECRUITING